Ahmed Abouzeid, Director, Oncology Category Lead at Pfizer, shared a post on LinkedIn:
“We Pfizer Egypt are proud to celebrate another enticing wave of partnership with Gustave Roussy International – Egypt, which has been instrumental in driving impactful Breast Cancer awareness most notably إنت أصل الحكايه during October and now once again through a significant scientific collaboration last week 1-2 November the ASCO Lung Cancer MCMC – a two-day Multidisciplinary Cancer Management Course featuring global and local experts in the field of lung cancer.
This course was vital opportunity to advance clinical knowledge in lung cancer management offering scientific dialogue, meaningful practice sharing, and collaboration between Egyptian experts and international thought leaders.
Inside the institute, participants did engage in high-impact sessions focused on early detection, diagnostic advancements, and shifting patient outcomes through evidence-based strategies.
We at Pfizer are proud to support this center of excellence and such public-private partnerships and are committed together to fostering innovation, knowledge exchange, and education aligned with global standards.
Special thanks to the incredible partners and contributors: Enjoy the replay.”
